Incannex Healthcare Inc. financial data

Symbol
IXHL on Nasdaq
Industry
Pharmaceutical Preparations
Location
401 Docklands Drive, Suite 15, Level 12, Docklands, Victoria, Australia
State of incorporation
Australia
Fiscal year end
June 30
Former names
Incannex Healthcare Ltd (to 11/29/2023)
Latest financial report
10-Q - Q3 2024 - Nov 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 330 %
Debt-to-equity 43.1 %
Return On Equity -182 %
Return On Assets -127 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 17.6M shares
Common Stock, Shares, Outstanding 17.6M shares
Entity Public Float 64M USD
Common Stock, Value, Issued 2K USD
Weighted Average Number of Shares Outstanding, Basic 17.6M shares +11.1%
Weighted Average Number of Shares Outstanding, Diluted 17.6M shares +11.1%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 74K USD
Research and Development Expense 13.2M USD +11%
General and Administrative Expense 18.3M USD +50.3%
Operating Income (Loss) -31.4M USD -27.8%
Nonoperating Income (Expense) 8.28M USD -80%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -23.1M USD -647%
Net Income (Loss) Attributable to Parent -23.2M USD -647%
Earnings Per Share, Basic -1.36 USD/shares -263%
Earnings Per Share, Diluted -1.36 USD/shares -263%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 3.63M USD
Assets, Current 15.2M USD
Property, Plant and Equipment, Net 428K USD
Operating Lease, Right-of-Use Asset 411K USD
Assets 16M USD
Employee-related Liabilities, Current 387K USD
Accrued Liabilities, Current 7.1M USD
Contract with Customer, Liability, Current 59K USD
Liabilities, Current 9.23M USD
Operating Lease, Liability, Noncurrent 221K USD
Liabilities 9.45M USD
Accumulated Other Comprehensive Income (Loss), Net of Tax -2.99M USD
Retained Earnings (Accumulated Deficit) -116M USD
Stockholders' Equity Attributable to Parent 6.6M USD -66.7%
Liabilities and Equity 16M USD

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -2.19M USD +61.9%
Net Cash Provided by (Used in) Financing Activities -52K USD
Net Cash Provided by (Used in) Investing Activities -221K USD
Common Stock, Shares Authorized 100M shares
Common Stock, Shares, Issued 17.6M shares
Common Stock, Par or Stated Value Per Share 0 USD/shares
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -2.23M USD +61.8%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 3.63M USD -77.7%
Operating Lease, Liability 411K USD
Depreciation 66.2M USD +449%
Payments to Acquire Property, Plant, and Equipment 221K USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -22.4M USD -311%
Lessee, Operating Lease, Liability, to be Paid 458K USD
Property, Plant and Equipment, Gross 625K USD
Operating Lease, Liability, Current 190K USD
Lessee, Operating Lease, Liability, to be Paid, Year Two 51K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 211K USD
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 47K USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 34K USD
Preferred Stock, Shares Authorized 10M shares
Unrecognized Tax Benefits 7.81M USD +29.9%
Lessee, Operating Lease, Liability, to be Paid, Year Four 38K USD
Additional Paid in Capital 126M USD
Share-based Payment Arrangement, Expense -459K USD -128%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares